Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Presse Medicale (Paris, France : 1983)|December 16, 1998
[Nephrotoxicity of ritonavir]G Deray, M Bochet, C Katlama, et al.Infection Control and Hospital Epidemiology|November 4, 1998
Mycobacterium avium complex common-source or cross-infection in AIDS patients attending the same day-care facilityA Carbonne, N Lemaitre, M Bochet, et al.Hepatology (Baltimore, Md.)|August 2, 2001
Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapyY Benhamou, V Di Martino, M Bochet, et al.Journal of Clinical Microbiology|August 17, 1999
Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virusV Thibault, Y Benhamou, C Seguret, et al.Hepatology (Baltimore, Md.)|October 26, 1999
Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patientsY Benhamou, M Bochet, V Thibault, et al.Hepatology (Baltimore, Md.)|September 25, 1999
Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc GroupY Benhamou, M Bochet, V Di Martino, et al.Lancet (London, England)|September 12, 2001
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot studyY Benhamou, M Bochet, V Thibault, et al.Gut|October 18, 2000
Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early reportH Zylberberg, Y Benhamou, J L Lagneaux, et al.Pageof 1